Article Detail - JE Part A
MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (L38643) - R2 - Effective June 02, 2022
This Local Coverage Determination (LCD) has been revised under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Medicare Coverage Database (MCD) Number: L38643
LCD Title: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
Effective Date: June 02, 2022
Summary of Changes:
Under CMS National Coverage Policy added regulation CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80.1.2 A/B MAC (B) Contacts with Independent Clinical Laboratories.
Visit the Molecular Diagnostic Services (MolDX) webpage to access the MolDX Medicare Local Coverage Determination from the “Active LCD” Webpage.
Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.